These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7867722)

  • 1. Plasminogen activator inhibitor type 2: an intracellular keratinocyte differentiation product that is incorporated into the cornified envelope.
    Jensen PJ; Wu Q; Janowitz P; Ando Y; Schechter NM
    Exp Cell Res; 1995 Mar; 217(1):65-71. PubMed ID: 7867722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor type 2 (PAI-2) is present in normal human conjunctiva.
    Massaro-Giordano M; Marshall CM; Lavker RM; Jensen PJ; Risse Marsh BC
    J Cell Physiol; 2005 Nov; 205(2):295-301. PubMed ID: 15887231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the level and glycosylation state of plasminogen activator inhibitor type 2 during human keratinocyte differentiation.
    Wang Y; Jensen PJ
    Differentiation; 1998 Jun; 63(2):93-9. PubMed ID: 9674118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes.
    Bator JM; Cohen RL; Chambers DA
    Exp Cell Res; 1998 Jul; 242(1):110-9. PubMed ID: 9665808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
    Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for intracellular cleavage of plasminogen activator inhibitor type 2 (PAI-2) in normal epidermal keratinocytes.
    Risse BC; Chung NM; Baker MS; Jensen PJ
    J Cell Physiol; 2000 Feb; 182(2):281-9. PubMed ID: 10623892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor 2: expression and role in differentiation of epidermal keratinocyte.
    Lian X; Yang T
    Biol Cell; 2004 Mar; 96(2):109-16. PubMed ID: 15050365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of plasminogen activator inhibitor-2 (PAI-2) in keratinocyte differentiation.
    Jang S; Yang TH; An EJ; Yoon HK; Sohn KC; Cho AY; Ryu EK; Park YS; Yoon TY; Lee JH; Kim CD
    J Dermatol Sci; 2010 Jul; 59(1):25-30. PubMed ID: 20494554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor type 2 in human corneal epithelium.
    Williams DL; Risse B; Kim S; Saunders D; Orlin S; Baker MS; Jensen PJ; Lavker RM
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1669-75. PubMed ID: 10393034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor type-2 (PAI-2) in human keratinocytes regulates pericellular urokinase-type plasminogen activator.
    Reinartz J; Schaefer B; Bechtel MJ; Kramer MD
    Exp Cell Res; 1996 Feb; 223(1):91-101. PubMed ID: 8635500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor type-2 in the lesional epidermis of lupus erythematosus.
    Bechtel MJ; Schaefer BM; Kramer MD
    Br J Dermatol; 1996 Mar; 134(3):411-9. PubMed ID: 8731662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.
    Feng Q; Liu Y; Liu K; Byrne S; Liu G; Wang X; Li Z; Ockleford CD
    Placenta; 2000; 21(2-3):184-93. PubMed ID: 10736241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAI-1 gene expression is growth state-regulated in cultured human epidermal keratinocytes during progression to confluence and postwounding.
    Staiano-Coico L; Carano K; Allan VM; Steiner MG; Pagan-Charry I; Bailey BB; Babaar P; Rigas B; Higgins PJ
    Exp Cell Res; 1996 Aug; 227(1):123-34. PubMed ID: 8806459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunolocalization of protein C inhibitor in differentiation of human epidermal keratinocytes.
    Zhang C; Li X; Lian X; Wang Y; Zeng Y; Yang K; Yu J; Gao Q; Yang T
    Acta Histochem; 2007; 109(6):461-7. PubMed ID: 17706750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator system in oral squamous cell carcinoma.
    Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
    Br J Oral Maxillofac Surg; 2007 Dec; 45(8):623-7. PubMed ID: 17590247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
    Nishida Y; Hayashi Y; Imai Y; Itoh H
    Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.
    Wells JM; Strickland S
    J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor type 2: potential prognostic factor for endometrial carcinomas.
    Osmak M; Babić D; Abramić M; Milicić D; Vrhovec I; Skrk J
    Neoplasma; 2001; 48(6):462-7. PubMed ID: 11949838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 and type 2 in stage I malignant melanoma.
    Stabuc B; Markovic J; Bartenjev I; Vrhovec I; Medved U; Kocijancic B
    Oncol Rep; 2003; 10(3):635-9. PubMed ID: 12684636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the plasminogen activator cascade during enhanced epidermal proliferation in vivo.
    Jensen PJ; Lavker RM
    Cell Growth Differ; 1996 Dec; 7(12):1793-804. PubMed ID: 8959348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.